UCB Drives Patient Engagement and ROI with Veeva eCOA

UCB, a large Brussels-headquartered biopharma company, sought to modernize and scale patient-engagement capabilities in clinical trials. It partnered with Veeva to deploy Veeva eCOA (electronic Clinical Outcome Assessment) for capturing patient-reported data in studies, alongside Veeva Clinical Operations. The rollout achieved "100% adoption on eligible studies, ahead of schedule" and is "delivering a strong return on investment," with projections to "save millions." Per Edwin Erckens, Chief Digital Technology Officer at UCB: "We received positive feedback from patients and site staff, and are delivering ROI, projected to save millions."

Veeva Systems is the dominant CRM and content platform in pharma commercial, regulatory, clinical and quality operations, now shipping AI agents directly inside those same production systems.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.